Flutiform inhalation suspension

Flutiform is a pressurized inhalation treatment containing fluticasone propionate and formoterol fumarate, used primarily for the management of asthma. The brand was developed through a partnership between Skyepharma and the Mundipharma network of independent associated companies. While the product is marketed globally, for the Spanish market, it is distributed and authorized via Mundipharma Pharmaceuticals, S.L., located in Madrid.

Manufacturing for this specific medication has historically been centered in the United Kingdom, specifically at the Holmes Chapel facility, which has served as a primary production hub for these complex delivery systems. The brand is part of the Mundipharma portfolio, a global high-tech pharmaceutical organization owned by the Sackler family, known for its extensive presence in pain management and respiratory care through various international entities.